|
|
#1
09-04-2015, 03:13 PM
|
|||
|
|||
AstraZeneca wins U.S. approval for longer use of blood thinner
(Reuters) - U.S. regulators have approved a new dose of AstraZeneca's blood thinner Brilinta for longer-term use in patients with a history of heart attacks, boosting prospects for a drug the company thinks will eventually sell $3.5 billion a year.  ??????? ??????: AstraZeneca wins U.S. approval for longer use of blood thinner || ??????: ahlam1399 || ??????: اسم منتداك
|
 |
|
|
العرض العادي
